These lines of evidence demonstrated that neurodegenerative changes during cognitive impairment may increase clusterin expression (Nuutinen et al., 2009), suggesting the beneficial role of clusterin in AD pathology. The gene discussed is CLU; the disease is Cognitive impairment.